These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11091768)

  • 41. Alternatives: a socio-political commentary from the USA.
    Rowan AN; Andrutis KA
    ATLA Abstr; 1990 Nov; 18():3-10. PubMed ID: 11659335
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of ICCVAM in evaluating new and alternative test methods.
    Stokes WS; Hill RN
    Lab Anim (NY); 2002; 31(7):26-32. PubMed ID: 12200591
    [No Abstract]   [Full Text] [Related]  

  • 43. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of immunosuppressants and antibiotics on human monoclonal antibody production in SCID mouse ascites by five heterohybridomas.
    Yoshinari K; Arai K
    Hybridoma; 1998 Feb; 17(1):41-5. PubMed ID: 9523236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stem cell decision time.
    Nat Genet; 2001 Jun; 28(2):99-100. PubMed ID: 11381244
    [No Abstract]   [Full Text] [Related]  

  • 46. Alternatives to animal experiments.
    von Aulock S
    ALTEX; 2014; 31(2):U2. PubMed ID: 24910879
    [No Abstract]   [Full Text] [Related]  

  • 47. Purification, characterisation and production of a monoclonal antibody to Cl. novyi type B alpha toxin.
    Whitworth K
    Dev Biol Stand; 1996; 86():347. PubMed ID: 8785987
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparison of the action of pristan and Freund's incomplete adjuvant on the development of ascites in mice--the recipients of hybridoma cells].
    Novikov VV; Trofimova MN; Zhil'tsova MA; Sandova OM
    Antibiot Khimioter; 1988 Jul; 33(7):530-2. PubMed ID: 3190349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for animal care committees and animal use oversight.
    Richmond J; Fletch A; Van Tongerloo R
    ILAR J; 2002; 43 Suppl():S129-32. PubMed ID: 12388867
    [No Abstract]   [Full Text] [Related]  

  • 50. Lessons learned from alternative methods and their validation for a new toxicology in the 21st century.
    Hartung T
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):277-90. PubMed ID: 20574902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality control of murine monoclonal antibodies using isoelectric focusing affinity immunoblot analysis.
    Hamilton RG; Reimer CB; Rodkey LS
    Hybridoma; 1987 Apr; 6(2):205-17. PubMed ID: 3552959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Government-owned inventions; availability for licensing. National Institutes of Health, Public Health Service, DHHS. Notice.
    Fed Regist; 1999 Feb; 64(37):9337-8. PubMed ID: 10557590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation and purification of monoclonal antibodies against Der f 2, a major allergen from Dermatophagoides farinae.
    Chen H; Zhang K; Wang S; Xu C; Zou Z; Tao A
    Drug Discov Ther; 2016; 10(2):103-8. PubMed ID: 27210892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. US government sets out Alzheimer's plan.
    Wadman M
    Nature; 2012 May; 485(7399):426-7. PubMed ID: 22622544
    [No Abstract]   [Full Text] [Related]  

  • 55. Monoclonal antibodies to a brain dopamine binding protein: production, specificity, and immunohistochemistry.
    Hsu LL; Moroi K; Lakchaura BD; Chan T; Lin CT; Wu JY
    J Neurosci Res; 1987; 17(4):417-23. PubMed ID: 3305971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction to the purification of antibodies.
    Grodzki AC; Berenstein E
    Methods Mol Biol; 2010; 588():11-3. PubMed ID: 20012813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Faring of animal research.
    Nat Immunol; 2000 Nov; 1(5):359. PubMed ID: 11062487
    [No Abstract]   [Full Text] [Related]  

  • 58. Why modification of the LD50 test will not be enough.
    Balls M
    Lab Anim; 1991 Jul; 25(3):198-206. PubMed ID: 1921314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The physician's stake in animal research.
    Wyngaarden JB
    JAMA; 1986 Aug; 256(5):634-5. PubMed ID: 3723763
    [No Abstract]   [Full Text] [Related]  

  • 60. Alternatives to animal experimentation in basic research.
    Gruber FP; Hartung T
    ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.